SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-129304
Filing Date
2019-04-30
Accepted
2019-04-30 16:09:03
Documents
7
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A d678705ddefa14a.htm DEFA14A 48300
2 GRAPHIC g678705bio1l.jpg GRAPHIC 5251
3 GRAPHIC g678705n2.jpg GRAPHIC 3962
4 GRAPHIC g678705page1.jpg GRAPHIC 2410
5 GRAPHIC g678705page2.jpg GRAPHIC 2427
6 GRAPHIC g678705page3.jpg GRAPHIC 2445
7 GRAPHIC g678705page4.jpg GRAPHIC 2441
  Complete submission text file 0001193125-19-129304.txt   76398
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19311 | Film No.: 19781749
SIC: 2836 Biological Products, (No Diagnostic Substances)